Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48.3M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.68M
-
Shares change
-
+46.1K
-
Total reported value, excl. options
-
$8.23M
-
Value change
-
+$224K
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$4.90
Significant Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q2 2024
22 filings reported holding INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value as of Q2 2024.
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.68M shares
of 48.3M outstanding shares and own 3.47% of the company stock.
Largest 10 shareholders include SAPIENT CAPITAL LLC (1.01M shares), VANGUARD GROUP INC (205K shares), BROWN ADVISORY INC (158K shares), Sigma Planning Corp (47.9K shares), GEODE CAPITAL MANAGEMENT, LLC (47.6K shares), Mesirow Financial Investment Management, Inc. (44.2K shares), BLAIR WILLIAM & CO/IL (37.8K shares), One Charles Private Wealth Services, LLC (31.8K shares), Bison Wealth, LLC (17.4K shares), and HRT FINANCIAL LP (15.9K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.